Condition
Primary Immune Thrombocytopenia clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Primary Immune Thrombocytopenia clinical trials that are recruiting, at sites in 3 countries (most in China (3), United States (2), Bangladesh (1)). By phase: Phase 3 (2), Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Primary Immune Thrombocytopenia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| What patients with primary ITP prefer in their treatment | — | East Hanover, New Jersey | Recruiting | Aug 25, 2026 |
| SG301 SC Injection safety in adults with primary ITP | Phase 2 | Fuzhou, Fujian and 21 other locations | Recruiting | Jul 17, 2026 |
| Romiplostim plus prednisone vs prednisone alone in adults with newly diagnosed ITP | Phase 3 | Long Beach, California and 2 other locations | Recruiting | Jul 13, 2026 |
| TQB3473 tablets for treating adult primary immune thrombocytopenia | Phase 3 | Hefei, Anhui and 52 other locations | Recruiting | Mar 28, 2025 |
| Using Eltrombopag as a first treatment for Primary Immune Thrombocytopenia | Phase 1/2 | Dhaka | Recruiting | Jul 31, 2024 |
| Long-term observation of children with primary immune thrombocytopenia | — | Tianjin | Recruiting | Oct 30, 2023 |
All recruiting trials (6)
-
What patients with primary ITP prefer in their treatment
This survey-based study in the US will ask adults with primary ITP about which treatment options they prefer and why.
-
SG301 SC Injection safety in adults with primary ITP
This Phase 2 study tests SG301 SC injection at two doses versus placebo in adults with primary immune thrombocytopenia to see if it is safe and helps raise platelet counts.
-
Romiplostim plus prednisone vs prednisone alone in adults with newly diagnosed ITP
This phase 3 trial tests whether adding romiplostim to prednisone helps adults with newly diagnosed primary ITP respond better than prednisone alone.
-
TQB3473 tablets for treating adult primary immune thrombocytopenia
This study is testing if TQB3473 tablets can help adults with chronic immune thrombocytopenia who haven't responded well to standard treatments feel better and have more stable blood platelet levels.
-
Using Eltrombopag as a first treatment for Primary Immune Thrombocytopenia
This study is testing if a new medication called eltrombopag can help people who are newly diagnosed with Primary Immune Thrombocytopenia by increasing their platelet counts and reducing bleeding.
-
Long-term observation of children with primary immune thrombocytopenia
This study looks at how children with primary immune thrombocytopenia are treated and what their long-term health outcomes are in order to better understand the condition.
Quick answers
How many Primary Immune Thrombocytopenia clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), United States (2 trials), Bangladesh (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.